{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:52:09Z","timestamp":1777909929341,"version":"3.51.4"},"reference-count":5,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1089\/jop.2019.0141","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T12:12:48Z","timestamp":1579781568000},"page":"205-205","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Re: \u201cCross-Linked Hyaluronic Acid as Tear Film Substitute\u201d by Posarelli et al. (\n                    <i>J Ocul Pharmacol Ther<\/i>\n                    2019;35(7):381\u2013387)"],"prefix":"10.1177","volume":"36","author":[{"given":"Barbara","family":"Wirostko","sequence":"first","affiliation":[{"name":"EyeGate Pharmaceuticals, Inc., Salt Lake City, Utah, USA."},{"name":"Moran Eye Center, University of Utah, Salt Lake City, Utah, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Mann","sequence":"additional","affiliation":[{"name":"EyeGate Pharmaceuticals, Inc., Salt Lake City, Utah, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren","family":"Stirland","sequence":"additional","affiliation":[{"name":"EyeGate Pharmaceuticals, Inc., Salt Lake City, Utah, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2018.0151"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2014.0572"},{"key":"e_1_3_1_4_2","first-page":"460437","article-title":"A crosslinked HA-based hydrogel ameliorates dry eye symptoms in dogs","author":"Williams D.L.","year":"2013","unstructured":"Williams D.L., , and Mann B.K. A crosslinked HA-based hydrogel ameliorates dry eye symptoms in dogs. Int. J. Biomater. 2013:460437.","journal-title":"Int. J. Biomater"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20848"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2018.01.018"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2019.0141","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2019.0141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2019.0141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:43:47Z","timestamp":1777646627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2019.0141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5,1]]}},"alternative-id":["10.1089\/jop.2019.0141"],"URL":"https:\/\/doi.org\/10.1089\/jop.2019.0141","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}